| Company Name: |
Accela ChemBio Co.,Ltd.
|
| Tel: |
021-50795510 4000665055 |
| Email: |
sales@accelachem.com |
| Products Intro: |
Product Name:5,5'-(1,4-Piperazinediyl)bis(2-aminopyridine)
CAS:2144748-14-9
Purity:>95% Package:0.1g;0.25g;1g;5g
|
|
| | Palbociclib-007 Basic information |
| Product Name: | Palbociclib-007 | | Synonyms: | Palbociclib-007;Palbociclib impurity 8/5,5'-(Piperazine-1,4-diyl)bis(pyridin-2-amine);5,5’-(1,4-Piperazinediyl)bis(2-aminopyridine);2-Pyridinamine, 5,5'-(1,4-piperazinediyl)bis-;5,5'-(Piperazine-1,4-diyl)bis(pyridin-2-amine);Palbociclib Impurity 37Q: What is
Palbociclib Impurity 37 Q: What is the CAS Number of
Palbociclib Impurity 37;Xylose Impurity 8 | | CAS: | 2144748-14-9 | | MF: | C14H18N6 | | MW: | 270.33 | | EINECS: | | | Product Categories: | | | Mol File: | 2144748-14-9.mol |  |
| | Palbociclib-007 Chemical Properties |
| Boiling point | 582.6±50.0 °C(Predicted) | | density | 1.299±0.06 g/cm3(Predicted) | | pka | 7.66±0.26(Predicted) |
| | Palbociclib-007 Usage And Synthesis |
| Uses | 5,5''-(Piperazine-1,4-diyl)bis(pyridin-2-amine) is an impurity of Palbociclib (P139900), an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. |
| | Palbociclib-007 Preparation Products And Raw materials |
|